Compounds > isospaglumic acid
Page last updated: 2024-09-05

isospaglumic acid and Demyelinating Diseases

isospaglumic acid has been researched along with Demyelinating Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berneman, Z; Daans, J; Guglielmetti, C; Hens, N; Kara, F; Orije, J; Ponsaerts, P; Praet, J; Santermans, E; Van der Linden, A; Verhoye, M1
Bonfiglio, T; Cervetto, C; Di Prisco, S; Grilli, M; Marchi, M; Merega, E; Olivero, G; Pittaluga, A; Usai, C1
Barritault, J; Engelke, UF; McNeill, NH; Mochel, F; Schiffmann, R; Seguin, F; Thompson, JN; Vanderver, A; Verheijen, FW; Wevers, RA; Willemsen, MA; Wolf, NI; Yang, B1
Halley, D; Holwerda, U; Jakobs, C; Sistermans, EA; Struys, E; van der Knaap, MS; van Spaendonk, RM; Wamelink, MM; Willemsen, MA; Wolf, NI1
Engelke, UF; Harting, I; Pouwels, PJ; Rating, D; Sistermans, EA; van der Knaap, MS; Wevers, RA; Willemsen, MA; Wolf, NI; Zschocke, J1

Other Studies

5 other study(ies) available for isospaglumic acid and Demyelinating Diseases

ArticleYear
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
    NMR in biomedicine, 2015, Volume: 28, Issue:4

    Topics: Animals; Aspartic Acid; Brain Chemistry; Choline; Creatine; Cuprizone; Demyelinating Diseases; Dipeptides; Disease Models, Animal; Female; Gliosis; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Neuroimaging; Oligodendroglia; Phosphocreatine; Proton Magnetic Resonance Spectroscopy

2015
Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease.
    British journal of pharmacology, 2016, Volume: 173, Issue:9

    Topics: Amino Acids, Dicarboxylic; Animals; Autoreceptors; Bridged Bicyclo Compounds; Central Nervous System; Demyelinating Diseases; Dipeptides; Dose-Response Relationship, Drug; Female; Male; Mice; Mice, Inbred C57BL; Presynaptic Terminals; Receptors, Metabotropic Glutamate; Structure-Activity Relationship; Synaptosomes

2016
Elevated CSF N-acetylaspartylglutamate in patients with free sialic acid storage diseases.
    Neurology, 2010, Jan-26, Volume: 74, Issue:4

    Topics: Child; Child, Preschool; Cross-Sectional Studies; Demyelinating Diseases; Dipeptides; Female; Genetic Testing; Genotype; Humans; Infant; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mutation; N-Acetylneuraminic Acid; Organic Anion Transporters; Sialic Acid Storage Disease; Symporters; Young Adult

2010
N-acetylaspartylglutamate in CNS hypomyelination.
    Neuropediatrics, 2011, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Child; Child, Preschool; Cohort Studies; Demyelinating Diseases; Dipeptides; Female; Humans; Infant; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Tritium; Young Adult

2011
Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF.
    Neurology, 2004, May-11, Volume: 62, Issue:9

    Topics: Biomarkers; Brain; Brain Diseases, Metabolic; Child; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Dipeptides; Female; Genotype; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mutation; Myelin Proteolipid Protein; Pelizaeus-Merzbacher Disease

2004